Behind the new groundbreaking Alzheimer's drug
Plus, how Neopets are making a comeback
Tech and Science Daily | The Standard · Rachelle Abbott
July 18, 20236m 55s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
How Donanemab gives patients months without symptoms. Extreme weather like Europe’s heatwave is ‘new normal’ - WMO. Could face scans end queues for Eurostar? Neopets are making a comeback. In this episode:
- Alzheimer’s Society’s Sian Gregory explains Donanemab drug breakthrough
- How hearing aids might reduce cognitive decline in adults at higher dementia risk
- Millions of US military emails ‘sent to Russia ally Mali by mistake due to typing errors’
- Face scans set up to cut congestion for Eurostar passengers
- Green turtles fed at same seagrass meadows 3,000 years ago
Follow us on Twitter or on Threads.
Hosted on Acast. See acast.com/privacy for more information.